Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7157204
Reference Type
Journal Article
Title
Prostaglandin E1 in infants with congenital heart disease: Indian experience
Author(s)
Saxena, A; Sharma, M; Kothari, SS; Juneja, R; Reddy, SC; Sharma, R; Bhan, A; Venugopal, P; ,
Year
1998
Is Peer Reviewed?
1
Journal
Indian Pediatrics
ISSN:
0019-6061
EISSN:
0974-7559
Language
English
PMID
10216540
Abstract
E-type prostaglandins (PGE1) can effectively maintain the patency of the ductus arteriosus in neonates. Its use, therefore and be life saving in infants born with ductus dependent congenital heart disease. Although PGE1 is available for over two decade in western world, it has been introduced in India only since April, 1995.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity